PET imaging of mitochondrial function in acute doxorubicin-induced cardiotoxicity: a proof-of-principle study

Felicitas J. Detmer, Nathaniel M. Alpert, Sung‐Hyun Moon, Maëva Dhaynaut, Jorge Guerrero, Nicolas J. Guehl, Fangxu Xing, Pedro Brugarolas, Timothy M. Shoup, Marc D. Normandin, Matthieu Pelletier‐Galarneau, Georges El Fakhri, Yoann PetibonScientific 2022 · DOI

Abstract

Mitochondrial dysfunction plays a key role in doxorubicin-induced cardiotoxicity (DIC). In this proof-of-principle study, we investigated whether PET mapping of cardiac membrane potential, an indicator of mitochondrial function, could detect an acute cardiotoxic effect of doxorubicin (DOX) in a large animal model. Eight Yucatan pigs were imaged dynamically with 18Ftriphenylphosphonium ([18F]FTPP+) PET/CT. Our experimental protocol included a control saline infusion into the left anterior descending coronary artery (LAD) followed by a DOX test infusion of either 1 mg/kg or 2 mg/kg during PET. We measured the change in total cardiac membrane potential (ΔΨT), a proxy for the mitochondrial membrane potential, ΔΨm, after the saline and DOX infusions. We observed a partial depolarization of the mitochondria following the DOX infusions, which occurred only in myocardial areas distal to the intracoronary catheter, thereby demonstrating a direct association between the exposure of the mitochondria to DOX and a change in ΔΨT. Furthermore, doubling the DOX dose caused a more severe depolarization of myocardium in the LAD territory distal to the infusion catheter. In conclusion, [18F]FTPP+ PET-based ΔΨT mapping can measure partial depolarization of myocardial mitochondria following intracoronary DOX infusion in a large animal model.

Introduction

Doxorubicin (DOX) is a highly effective chemotherapeutic agent, yet its clinical utility is often limited by dose-dependent cardiotoxicity. Currently, monitoring for doxorubicin-induced cardiotoxicity (DIC) relies on measuring the Left Ventricular Ejection Fraction (LVEF). However, LVEF is a "lagging indicator"—by the time a drop in pump function is detectable, significant and often irreversible myocardial damage has already occurred. There is a critical need for "leading indicators" that can detect subclinical cellular injury. Mitochondrial dysfunction is recognized as one of the earliest events in DIC, making the imaging of mitochondrial health a promising avenue for early detection.

Methods

The study utilized the specialized PET tracer [18F]FTPP+, a lipophilic cation that accumulates in healthy mitochondria based on their negative membrane potential (ΔΨm). A drop in this potential (depolarization) leads to reduced tracer uptake.

Eight Yucatan pigs were used as a large animal model due to their physiological similarity to humans. The experimental protocol involved dynamic [18F]FTPP+ PET/CT imaging. Each animal served as its own control: a saline infusion was first administered into the Left Anterior Descending (LAD) coronary artery, followed by a DOX infusion at either 1 mg/kg (Group A) or 2 mg/kg (Group B).

Experimental protocol for Group A and Group B, illustrating the timing of saline and doxorubicin (DOX) infusions.

Kinetic modeling and CT-derived extracellular volume (fECV) were used to calculate the total tissue membrane potential (ΔΨT) in millivolts. By using intracoronary infusion, the researchers could compare the affected LAD territory directly with untreated segments (e.g., Right Coronary Artery (RCA) territory) within the same heart.

Results

The study successfully demonstrated that DOX causes acute mitochondrial depolarization. Following DOX infusion, a significant drop in tracer uptake was observed specifically in the LAD territory distal to the infusion site, while no such change occurred after saline infusion or in the RCA territory.

Time-activity curves showing the specific drop in tracer uptake in the LAD territory following DOX infusion, compared to the stable RCA territory.

Key findings include:

  • Significant Depolarization: DOX infusion led to a partial depolarization of myocardial mitochondria, with ΔΨT changes ranging from 2.5 to 10.5 mV (p < 0.0001).
  • Dose-Response Relationship: Doubling the DOX dose from 1 mg/kg to 2 mg/kg resulted in a significantly more severe drop in membrane potential (p = 0.0013).
  • Direct Causality: The localized nature of the depolarization confirms that the PET signal change is a direct consequence of DOX exposure, rather than a systemic stress response.
  • Potential for Recovery: In the lower-dose group, tracer concentrations showed signs of stabilization or recovery post-infusion, suggesting that early mitochondrial "stunning" might be reversible.

Discussion and Future Directions

This proof-of-principle study demonstrates that [18F]FTPP+ PET-based mapping of ΔΨT can detect acute mitochondrial injury caused by DOX before functional decline occurs. However, several steps remain for clinical translation. This study focused on acute, high-dose exposure; future research must evaluate if this technique can detect the cumulative damage typical of chronic clinical dosing. Additionally, while the intracoronary approach provided strong internal controls, validating the sensitivity of the method with standard intravenous administration is necessary for routine clinical use. Defining the threshold of depolarization that predicts irreversible heart failure will also be crucial for guiding clinical interventions.

Summary updated

Abstract

Mitochondrial dysfunction plays a key role in doxorubicin-induced cardiotoxicity (DIC). In this proof-of-principle study, we investigated whether PET mapping of cardiac membrane potential, an indicator of mitochondrial function, could detect an acute cardiotoxic effect of doxorubicin (DOX) in a large animal model. Eight Yucatan pigs were imaged dynamically with [<sup>18</sup>F](4-Fluorophenyl)triphenylphosphonium ([<sup>18</sup>F]FTPP<sup>+</sup>) PET/CT. Our experimental protocol included a control saline infusion into the left anterior descending coronary artery (LAD) followed by a DOX test infusion of either 1 mg/kg or 2 mg/kg during PET. We measured the change in total cardiac membrane potential (ΔΨ<sub>T</sub>), a proxy for the mitochondrial membrane potential, ΔΨ<sub>m</sub>, after the saline and DOX infusions. We observed a partial depolarization of the mitochondria following the DOX infusions, which occurred only in myocardial areas distal to the intracoronary catheter, thereby demonstrating a direct association between the exposure of the mitochondria to DOX and a change in ΔΨ<sub>T</sub>. Furthermore, doubling the DOX dose caused a more severe depolarization of myocardium in the LAD territory distal to the infusion catheter. In conclusion, [<sup>18</sup>F]FTPP<sup>+</sup> PET-based ΔΨ<sub>T</sub> mapping can measure partial depolarization of myocardial mitochondria following intracoronary DOX infusion in a large animal model.
BibTeX
@inproceedings{detmer2022pet,
  author = {Felicitas J. Detmer and Nathaniel M. Alpert and Sung‐Hyun Moon and Maëva Dhaynaut and Jorge Guerrero and Nicolas J. Guehl and Fangxu Xing and Pedro Brugarolas and Timothy M. Shoup and Marc D. Normandin and Matthieu Pelletier‐Galarneau and Georges El Fakhri and Yoann Petibon},
  title = {{PET imaging of mitochondrial function in acute doxorubicin-induced cardiotoxicity: a proof-of-principle study}},
  booktitle = {Scientific},
  year = {2022},
  doi = {10.1038/s41598-022-10004-6},
}
Figure